UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
BCTXZ holding history
BriaCell Therapeutics Corp. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BCTXZ overviewAll 13F holders of BCTXZFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −4,697−100.0% | Sold out | Holders |
| Q1 2026 | 4,697 | $658 | <0.1% | +4,692+93,840.0% | Added | Holders |
| Q4 2025 | 5 | $1 | <0.1% | −61−92.4% | Reduced | Holders |
| Q3 2025 | 66 | $22 | <0.1% | −1,123−94.4% | Reduced | Holders |
| Q2 2025 | 1,189 | $1.26K | <0.1% | +1,189 | New | Holders |